Marksans Pharma Ltd Financials Statements

Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios

Consolidate
Standalone
Financial Year
Dec '23
Sep '23
Jun '23
Mar '23
Dec '22
Total Qtr Revenue cr
590.93
550.23
510.13
496.99
497.48
Other Income Qtr Cr4.8019.0010.1011.0117.65
Operating Revenues Qtr586.13531.24500.03485.98479.83

*All values are in Cr.

Operating Expenses Qtr
453.11
417.29
398.07
376.43
403.19
Operating Profit Qtr
133.02
113.95
101.97
109.55
76.64
EBIDT Qtr Cr
137.82
132.95
112.06
120.56
94.30
Depreciation Qtr
22.00
17.55
13.66
13.94
12.74
Net Profit Qtr
83.24
83.52
68.66
81.93
63.41
Basic EPS Qtr
1.84
1.84
1.52
1.97
1.56
Open Demat Account
or Resume your Application
+91 -

personImage